共 193 条
[21]
Wager E(2008)Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation JAMA 299 1800-546
[22]
Middleton P(2008)The ADVANTAGE seeding trial: a review of internal documents Ann Intern Med 149 251-962
[23]
Altman DG(2003)Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial Ann Intern Med 139 539-719
[24]
Schulz KF(2009)Pfizer settles largest ever fraud suit for off-label promotion Nat Biotechnol 27 961-56
[25]
Krumholz HM(2003)Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis J Rheumatol 30 714-237
[26]
Ross JS(1989)Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal, antiinflammatory drugs in rheumatoid arthritis Controlled Clin Trials 10 31-592
[27]
Presler AH(1996)Influences on the quality of published drug studies Int J Tech Assess Health Care 12 209-1173
[28]
Egilman DS(2002)Design and reporting modifications in industry-sponsored comparative psychopharmacology trials J Nerv Ment Dis 190 583-1288
[29]
Knijff-Dutmer EAJ(2003)Evidence b(i)ased medicine -selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications BMJ 326 1171-2635
[30]
Martens A(2007)Factors associated with findings of published trials of drug–drug comparisons: why some statins appear more efficacious than others PLoS Med 4 e184-2586